4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-004190
CHIEF EXECUTIVE OFFICER bought 30,000 shares at $2.83 ($84,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-06-06 | Purchase | +30,000 | $2.83 | $84,900 | 5,261,873 | D |
| Open-market purchases · 30,000 sh · avg $2.83 · $84,900 | |||||||
Loading xslF345X03/ownership.xml…